Slide 1: F'13 - Q1 Financial Results
F'13 - Q1 Financial Results November 15, 2012 November 15, 2012 BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS
Slide 2: Forward-Looking Statements
FORWARD-LOOKING STATEMENTS BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 2 In this presentation, statements that are not reported financial results or other historic information are "forward-looking statements." These forward-looking statements relate to, among other things, the Company's future financia
Slide 3: Q1 F'13 - Financial Summary
Q1 F'13 - FINANCIAL SUMMARY Net income down 16.9% to $27.2M vs. $32.7M in Q1 of F'12. Net Income, excluding the losses on the sales of Brady Medical and Varitronics** was down 7.1% to $30.4M vs. $32.7M in Q1 of F'12. Diluted EPS down 14.5% to $0.53 in Q1 of F'13 vs. $0.62 in Q1 of F'12. Diluted EPS,
Slide 4: F'13 Guidance Unchanged
F'13 GUIDANCE UNCHANGED BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 4 Diluted EPS $2.20 to $2.40 (Excluding after-tax restructuring charges and gains and losses on the sales of businesses) Guidance Assumptions: Full-year income tax rate in the mid-to-upper 20% range. Diluted share count consistent with
Slide 5: Sales Overview
SALES OVERVIEW Organic Sales 2% 10% 1% (0.6%) 3.5% (1.8%) (0.5%) (2.6%) (1.9%) BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 5 Q1 F'13 Sales Down 3.4%. (1.9%) Organic Sales Decline. 0.6% Growth from acquisitions, net of divestitures (2.1%) Decline due to currency translation. Americas - Growth in North A
Slide 6: Gross Profit Margin and SG&A
GROSS PROFIT MARGIN AND SG&A BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 6 GROSS PROFIT & GPM% (Millions of USD) SG&A & SG&A as % of SALES (Millions of USD) GPM of 48.8% is up 80 bps from Q1 of F'12. Increased GPM driven by mix, productivity improvements, and strategic sourcing benefits. GROSS PROFIT M
Slide 7: Net Income and Diluted EPS
NET INCOME* AND DILUTED EPS* Q1 F'13 diluted EPS down 14.5% to $0.53. Q1 F'13 diluted EPS, excluding the losses on the sales of Brady Medical and Varitronics was down 4.8% to $0.59. Improvements in Asia driving a rebound in net income when compared to Q4 of F'12. Benefits from restructuring being re
Slide 8: Cash Generation
CASH GENERATION BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 8 Cash Flow from Operating Activities = $20.2M. Returned $9.7M to our shareholders in dividends. Acquired 188,167 shares for $5.1M in Q1 of F'13. CASH BALANCE WALK (Millions of USD) CASH GENERATION - Q1 F'13:
Slide 9: Debt & EBITDA
DEBT & EBITDA BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS NET DEBT / TTM EBITDA* October 31, 2012 Cash = $321M. October 31, 2012 Debt = $321M. STRONG BALANCE SHEET: 9 DEBT & TTM EBITDA* (Millions of USD) * See slide #16 for the calculation of EBITDA.
Slide 10: Q1 F'13 - New Product Launches
Q1 F'13 - NEW PRODUCT LAUNCHES BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 10 Global Lock Out Procedure Field Application - Mobile software tool that provides on-line access to procedures and signage to improve the efficiency and field engineer productivity to meet or exceed OSHA requirements.
Slide 11: Americas - Q1 F'13 Summary
AMERICAS - Q1 F'13 SUMMARY Q1 F'12 Q1 F'13 Change Sales $ 153.9 $ 148.7 - 3.4% Segment Profit 43.2 44.6 + 3.2% Segment Profit % 28.1% 30.0% + 1.9 pts BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 11 SALES & SEGMENT PROFIT % (Millions of USD) Q1 F'13 vs. Q1 F'12 PERFORMANCE Revenues down (3.4%): Organic =
Slide 12: EMEA - Q1 F'13 Summary
EMEA - Q1 F'13 SUMMARY Q1F'12 Q1 F'13 Change Sales $97.4 $ 93.2 - 4.2% Segment Profit 26.3 23.6 - 10.3% Segment Profit % 27.0% 25.3% - 1.7 pts BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 12 SALES & SEGMENT PROFIT % (Millions of USD) Q1 F'13 vs. Q1 F'12 PERFORMANCE Revenues down (4.2%): Organic = (3.2%)
Slide 13: Asia-Pacific - Q1 F'13 Summary
ASIA-PACIFIC - Q1 F'13 SUMMARY Q1 F'12 Q1 F'13 Change Sales $ 98.3 $ 95.7 - 2.6% Segment Profit 13.3 12.1 - 9.0% Segment Profit % 13.5% 12.6% - 0.9 pts BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 13 SALES & SEGMENT PROFIT % (Millions of USD) Q1 F'13 vs. Q1 F'12 PERFORMANCE Revenues down (2.6%): Organic
Slide 14: Investor Relations
INVESTOR RELATIONS Brady Contact: Aaron Pearce Investor Relations 414-438-6895 Aaron_Pearce@Bradycorp.com See our web site at www.investor.bradycorp.com BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 14
Slide 15: Income Statements
INCOME STATEMENTS BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 15 COMPARABLE INCOME STATEMENT (Millions of USD)
Slide 16: EBITDA Reconciliation
EBITDA RECONCILIATION BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 16 EBITDA (Millions of USD)
Slide 17: Diluted EPS, Excluding Losses on the Sales of Businesses
Diluted EPS, Excluding Losses on the Sales of Businesses BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 17 Reconciliation of Diluted EPS, Excluding Losses on the Sales of Brady Medical and Varitronics:
Slide 18: Net Income, Excluding Losses on the Sales of Businesses
Net Income, Excluding Losses on the Sales of Businesses BRADY - FISCAL 2013 Q1 FINANCIAL RESULTS 18 Reconciliation of Net income, Excluding Losses on the Sales of Brady Medical and Varitronics ('000s of USD):